NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results

Go back to NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results

NuVasive (NUVA) PT Lowered to $65 at RBC Capital

February 21, 2019 8:29 AM EST

RBC Capital analyst Glenn Novarro lowered the price target on NuVasive (NASDAQ: NUVA) to $65.00 (from $70.00) while maintaining a Outperform rating.

... More

NuVasive (NUVA) Tops Q4 EPS by 6c, Offers FY Guidance

February 20, 2019 4:04 PM EST

NuVasive (NASDAQ: NUVA) reported Q4 EPS of $0.69, $0.06 better than the analyst estimate of $0.63. Revenue for the quarter came in at $288.3 million versus the consensus estimate of $290.96 million.

GUIDANCE:

NuVasive sees FY2019 EPS of $2.20-$2.30, versus the consensus of $2.47. NuVasive sees... More